HIV cure ‘smacks of quackery’ – scientist
Gammora, a drug being developed by Israeli biomedical company Zion Medical, is being sold to the world as a breakthrough in the fight against HIV, even offering a “potential cure”.
Prominent Twitter parody account @AdvBarryRoux, which has almost half a million followers, has been tweeting about the new ‘wonder’ drug.
“A drug for HIV cure just passed it’s first clinical human trial it was announced last night. The name is called Gammora. relief to those infected by HIV. They will get cured [sic],” he tweeted. By 14:00 on Tuesday, this tweet had received 2 600 likes and 1 700 retweets.
https://twitter.com/AdvBarryRoux/status/1059690960865648640
Twitter user @CawntryBoy responded with: “Gammora is said to have wiped off 99% of the virus in 14 days.That’s a huge sigh of relief to our infected family.”
Many other Twitter users have responded similarly enthusiastically believing the sweeping claims.
“This drug is designed to kill HIV-infected cells, without harming uninfected cells, working different than antiretroviral drugs. Retweet For Awareness,” read another one of @AdvBarryRoux’s tweets which has been retweeted over 1 100 times already [at 14:00].
https://twitter.com/AdvBarryRoux/status/1059730144577966080
The HIV world has been plagued by denialism and quacks promoting cures which has hurt the AIDS fight and resulted in unnecessary deaths.
HIV quackery
“The HIV world has seen quackery in different forms for decades – sadly this smacks of more of it,” prominent HIV scientist, Professor Francois Venter from the University of Witwatersrand’s Reproductive Health and HIV Institute, told Health-e News.
He said that saying the drug is a potential cure with no side-effects are “over-the-top biological claims that appear in public before the formal literature [is published] and should be viewed with deep scepticism”.
Health-e News could not find Zion Medical’s results published in any peer-reviewed scientific or medical journal and the company had not responded to requests for a copy by the time of writing.
“I looked at the press report and the unsophisticated company website, and even if you believe their claims, they are many years away from testing them,” said Venter.
He said: “This gives science and scientists a bad name.” – Health-e News
An edited version of this story was published by News24.com.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
HIV cure ‘smacks of quackery’ – scientist
by Amy Green, Health-e News
November 6, 2018
Related
Bibi-Aisha Wadvalla appointed to head up Health-e News
Bibi-Aisha Wadvalla took over the reigns at Health-e News in the beginning of June. The team is excited to welcome her and her new ideas that promise to breathe new life into the organisation.
Listen: Cryptococcal meningitis – Health-e News on SAfm
News Editor Amy Green was interviewed on SAfm Radio on Life Happens with Phemelo Motene about her story on cryptococcal meningitis – the second leading killer of people living with HIV.
In Focus: Global strategy to end cryptococcal meningitis in people living with HIV
Cryptococcal meningitis is the second biggest killer of people living with HIV after tuberculosis (TB). Now, a global initiative, the Ending Cryptococcal Meningitis Deaths by 2030 Strategic Framework aims to get the gold standard drug to treat the disease – flucytosine – registered in countries that need it. By Amy Green for Spotlight and Health-e News.